Rockwell Medical (RMTI) Enterprise Value (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Enterprise Value came in at -$23.9 million in Q1 2026, down 37.85% YoY from -$38.4 million in Q1 2025, and up 4.43% on a QoQ basis from -$25.0 million in Q4 2025.
Rockwell Medical (RMTI) Enterprise Value (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Enterprise Value data on file, last reported at -$23.9 million in Q1 2026.
- Quarterly Enterprise Value fell 37.85% year-over-year to -$23.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.9 million (down 37.85% YoY) and the FY2025 annual result came in at -$25.0 million, down 15.72% from the prior year.
- Enterprise Value climbed to -$23.9 million in Q1 2026, from -$25.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$8.6 million in Q1 2024 to a low of -$30.8 million in Q2 2022.
- A 5-year average of -$18.4 million and a median of -$18.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 78.54% — and 2025, when it slumped 101.08%.
- Tracing RMTI's Enterprise Value over 5 years: stood at -$21.5 million in 2022, then jumped by 49.12% to -$10.9 million in 2023, then slumped by 97.55% to -$21.6 million in 2024, then dropped by 15.72% to -$25.0 million in 2025, then increased by 4.43% to -$23.9 million in 2026.
- The last three Enterprise Value figures came in at -$23.9 million (Q1 2026), -$25.0 million (Q4 2025), and -$23.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | -24.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.80 Mn |
| Mar 31, 2026 | -23.89 Mn |
| Dec 31, 2025 | -25.00 Mn |
| Sep 30, 2025 | -23.71 Mn |
| Jun 30, 2025 | -18.42 Mn |
| Mar 31, 2025 | -17.33 Mn |
| Dec 31, 2024 | -21.60 Mn |
| Sep 30, 2024 | -18.27 Mn |
| Jun 30, 2024 | -11.86 Mn |
| Mar 31, 2024 | -8.62 Mn |
| Dec 31, 2023 | -10.94 Mn |
| Sep 30, 2023 | -11.73 Mn |
| Jun 30, 2023 | -14.87 Mn |
| Mar 31, 2023 | -16.83 Mn |
| Dec 31, 2022 | -21.49 Mn |
| Sep 30, 2022 | -27.56 Mn |
| Jun 30, 2022 | -30.78 Mn |
| Mar 31, 2022 | -9.90 Mn |
| Dec 31, 2021 | -22.44 Mn |
| Sep 30, 2021 | -33.20 Mn |